Major obstacles to the successful treatment of gliolastoma multiforme are mostly related to the acquired resistance to chemotherapy drugs and, after surgery, to the cancer recurrence in correspondence of residual microscopic foci. As innovative anticancer approach, low-intensity electric stimulation represents a physical treatment able to reduce multidrug resistance of cancer and to induce remarkable anti-proliferative effects by interfering with Ca 2+ and K + homeostasis and by affecting the organization of the mitotic spindles. However, to preserve healthy cells, it is utterly important to direct the electric stimuli only to malignant cells. In this work, we propose a nanotechnological approach based on ultrasound-sensitive piezoelectric nanoparticles to remotely deliver electric stimulations to glioblastoma cells. Barium titanate nanoparticles (BTNPs) have been functionalized with an antibody against the transferrin receptor (TfR) in order to obtain the dual targeting of blood-brain barrier and of glioblastoma cells. The remote ultrasound-mediated piezo-stimulation allowed to significantly reduce in vitro the proliferation of glioblastoma cells and, when combined with a sub-toxic concentration of temozolomide, induced an increased sensitivity to the chemotherapy treatment and remarkable anti-proliferative and pro-apoptotic effects.
INTRODUCTION
Despite the dramatic efforts to develop diagnostic and therapeutic tools, the treatment of brain cancer remains a huge challenge in oncology, and successful treatments are still far from being attained. The main obstacles to the successful treatment of brain tumors include i) the structural complexity of the central nervous system, ii) the recurrence of the tumors, and iii) the acquired drug resistance during chemotherapy. 1 The most common and detrimental primary brain tumor among adults is represented by glioblastoma multiforme (GBM), a particularly aggressive malignant astrocytoma. Although various treatments are available for GBM, including surgical resection, chemotherapy, and radiation, prognosis remains extremely poor. 2 The average survival time following diagnosis of GBM patients is only fourteen months, while the five-year survival rate is about 5%.
As alternative anticancer approaches, effective physical treatments based on low-intensity alternating currents (AC) demonstrated great potential for inhibiting the proliferation of different kind of cancer cells without the use of any drug/chemical. 3, 4 Specifically, AC is known to inhibit cell division by interfering with Ca 2+ and K + homeostasis and with the cytoskeletal components involved in cell division. Low-intensity AC resulted able to enhance the efficacy of a standard chemotherapy drug, temozolomide (TMZ), by reducing multidrug resistance, 5 and have been recently tested in combination with TMZ for the treatment of glioblastoma multiforme in clinical trials. 6, 7 The involved mechanism seems to be mediated by a AC-dependent translocation of the drug transporter P-glycoprotein (P-gp) from the plasma membrane to the cytosol. 5 However, healthy brain cells (i.e., human astrocytes) are also sensitive to AC-dependent antiproliferative effects 3 and, in this context, the local delivery of electrical stimuli to cancer cells is highly desirable.
The rapid development of innovative nanotechnological tools is allowing for the targeting of remote physical stimulations (e.g., thermal, electrical, oxidative, ionic, etc.) in deep tissues. 8 In the field of nano-oncology, different nanotransducers have been designed to mediate photothermal, photodynamic, or magnetothermal conversion, and to locally deliver anticancer stimuli at tumor level. 9 These nanotechnology-assisted remote stimulation approaches exploit a non-invasive source of energy, such as, for example, alternated magnetic fields and near-infrared radiations, which penetrates the biological tissues and is finally transduced by the nanomaterial into another potential toxic form of energy (e.g., heat).
In this context, our group proposed, for the first time in the literature, the remote electric stimulation of living cells mediated by piezoelectric nanoparticles, 10, 11 an extremely interesting approach for the modulation of cell behavior and activities. 12, 13 Taking advantage of the direct piezoelectric effect, these nanomaterials have been exploited to convert mechanical into electrical energy. 14, 15 Electric potentials can be generated by piezoelectric nanoparticles in remote modality by using ultrasounds (US), 16 mechanical pressure waves that can be safely and efficiently conveyed into deep tissues. Electro-elastic mathematical models 11 allowed to estimate, at nanoparticle level, the magnitude of the output voltage (φ output ~ 0.5 mV) evoked in response to US intensity I US = 0.8 W/cm 2 , while electrophysiological recordings 17 and real-time Ca 2+ /Na + imaging 11 of electrically excitable cells experimentally demonstrated the efficacy of nanoparticle-assisted piezo-stimulation. Recently, our group successfully exploited the antiproliferative effects of nanoparticle-assisted remote electric stimulation as non-invasive "wireless" therapy suitable for inhibiting proliferation of SK-BR3 breast cancer cells. 18 Similarly to low-intensity AC, chronic piezo-stimulations resulted able to inhibit cancer cell cycle progression by interfering with Ca 2+ homeostasis, by upregulating the gene expression of inward rectifier potassium channels, and by affecting the developing of the mitotic spindles during cell division. 18 Associated to the difficulties of treatment of pathologies at the level of the central nervous system, we find the problem of blood-brain barrier (BBB) crossing. The recent growth of nanotechnology promises to revolutionize the delivery of nanomaterials across BBB to brain cancers. 19 At first instance, the delivery of different nanomaterials through the BBB at the tumor site can be efficiently obtained by taking advantage of the enhanced permeability and retention (EPR) effect. 20 This phenomenon is associated to a highly fenestrated and permeabilized BBB in correspondence of newly formed tumor vessels. A complementary strategy, that appears to be particularly relevant for diagnostic and therapeutic purposes, is the functionalization of nanomaterials with specific ligands to promote their BBB crossing and their targeting to specific cell types or anatomical districts. 21 Typical receptors on cancer cell membrane, as the folate, the transferrin, or the epidermal growth factor (EGF) receptors, can be targeted for an efficient delivery of nanostructures to cancer cells. Particular attention has been dedicated to the antibody against the transferrin receptor (anti-TfR Ab), since it can be successfully exploited as a dualtargeting ligand for both enabling the BBB-crossing and the uptake by cancer cells. [22] [23] [24] [25] In this work, we report the preparation of functionalized piezoelectric nanoparticles for in vitro BBB crossing, active glioblastoma cell targeting, imaging, and remote electric treatment. To this aim, tetragonal crystalline barium titanate nanoparticles (BTNPs) have been chosen as lead-free piezoelectric nanotransducers 26 because of their excellent level of biocompatibility, 27 high piezoelectric coefficient (d 33 ~ 30 pm/V), 28 peculiar optical properties, [29] [30] [31] and possibility to finely control their morphology. 32 Finally, the synergic effects of the chronic piezoelectric stimulation combined with sub-toxic TMZ treatment have been in vitro investigated.
MATERIALS AND METHODS

Nanoparticle functionalization with anti-TfR antibody (AbBTNPs)
Non-centrosymmetric piezoelectric barium titanate nanoparticles were purchased by Nanostructured & Amorphous Materials, Inc (nominal nanoparticle size 300 nm in diameter, as indicated by the provider, purity > 99.9%). In the literature, many different dispersing agents have been adopted to obtain a stable dispersion of these nanoparticles, like poly(vinylpyrrolidone) (PVP), 33 hexamethylenetetramine (HMT), 34 ascorbic acid, 35 and ethanolamine. 35 In this work, a wrapping with the amphiphilic 1,2-distearoyl-sn-glycero-3- Sonoplus) and, after a centrifugation step (20 min at 900 rcf, Hettich®Universal 320/320R centrifuge), supernatant containing free DSPE-PEG was discharged. The wrapped nanoparticles were thereafter washed twice in ddH 2 O and finally re-dispersed at a 5 mg/ml concentration in ddH 2 O (for electron microscopy imaging), in PBS (for estimation of functionalization efficiency), or in complete cell medium (for stability studies and for biological experiments).
Concerning the nanoparticle functionalization with the antibody against the transferrin receptor, BTNPs were firstly coated with biotin-DSPE-PEG (20 % w/w, Nanocs, purity > 95%) and DSPE-PEG (80 % w/w), and subsequently conjugated to streptavidin-Ab anti-TfR (2.5 µg of Ab / mg of BTNPs, Abcore), similarly as described in a previous work. 18 Ab-functionalized BTNPs will be indicated in the text as AbBTNPs. DPSE-PEG-coated BTNPs have been used as control and will be indicated in the following as BTNPs for easiness of reading. The non-functionalized plain BTNP powder will be indicated as plain BTNPs. The quantification of Ab functionalization efficiency was carried out through the bicinchoninic acid (BCA) assay following the manufacturers' procedures (enhanced test tube protocol, Thermo Fisher).
Nanoparticle size, Z-potential, and polydispersity of AbBTNP and BTNP suspension (100 μg/ml) were characterized by using dynamic light scattering (DLS, Nano Z-Sizer 90, Malvern Instrument); the dynamic measurements of size and polydispersity were performed every ten minutes for two hours. Fourier-transformed infrared spectroscopy (FT-IR) was performed using a Shimadzu Miracle 10 as previously described. 36 
Multimodal imaging of BTNPs
Imaging of BTNPs was performed by using scanning electron microscopy (SEM), second harmonic generation (SHG) microscopy, and confocal laser scanning microscopy (CLSM). A drop of the diluted BTNP dispersion (100 μg/ml) was deposited and let dry on a glass coverslip.
SHG imaging of tetragonal crystal lattice of piezoelectric BTNPs was carried out with a multimodal custom-made non-linear microscope using a femtosecond pulsed laser source (Discovery, Coherent Inc.) for excitation. Images were acquired using an excitation wavelength of 800 nm and a 20X water immersion objective lens (XLUM 20X 0.95 NA, Olympus Corporation). SHG signal at 400 nm was collected in the epi-direction using a dichroic filter.
Emission spectrum was obtained exciting with a pump-and-probe beam at 810 nm and a Stokes beam at 1060 nm.
BTNPs were also detected by CLSM (C2s system, Nikon) with a 642 nm laser (emission collected at 670 nm < λ em < 750 nm), as showed elsewhere. 6 at room temperature; then cells were en bloc stained with 3 % solution of uranyl acetate in 20 % ethanol; finally, they were dehydrated and embedded in epoxy resin (Epon 812, Electron Microscopy Science). Polymerization has been performed for 48 h at 60°C. Samples were then sectioned with a UC7 Leica ultramicrotome equipped with a 45° diamond knife (DiATOME), and the slices of 80-90 nm were collected on 300 mesh copper grids. The ultrastructural analysis was performed by using a Zeiss Libra 120
Plus instrument operating at 120 kV equipped with an in-column omega filter. Investigations of nanoparticle internalization were also performed on U-87 cells (ATCC ® HTB-14), a cell line derived from a human primary glioblastoma that is well characterized and commonly used in brain cancer research. 38 The composition of the medium used for culturing U-87 cells was the same of that for bEnd.3 cells (U-87 seeding density 2·10 4 cells/cm 2 ).
Internalization studies were performed by incubating 100 µg/ml of nanoparticles directly on U-87 cells seeded on 35 mm µ-dish (Ibidi). Alternatively, U-87 cells were seeded in the abluminal compartment of the transwell and 100 µg/ml of nanoparticles were dispersed in cell medium of the luminal compartment. Staining, CLSM imaging, and image analysis were carried out as Figure S1 ).
Chronic ultrasound (US) stimulations and temozolomide (TMZ) treatment
US were generated by a KTAC-4000 device (Sonidel) through a tip transducer (S-PW 3 mm diameter tip). Chronic US stimulations were applied with 1 W/cm 2 intensity and 1 MHz frequency. Single US stimuli lasted 200 ms and were delivered every 2 s, 1 h per day, for 4 days.
This protocol of US treatment was chosen since was not able to detectably increase the temperature of the cell medium neither to affect cell behavior / proliferation. 17, 18 Concerning TMZ treatment, different concentrations of the drug (0-400 μg/ml) were assessed at 24 and 72 h in order to evaluate TMZ effects. The highest non-toxic concentration (50 μg/ml) was then tested in combination with US stimulations.
Cell viability assays
Metabolism of cell cultures after the treatment with temozolomide (TMZ, Sigma-Aldrich) and after chronic US stimulation was assessed with WST-1 Assay Reagent ((2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium sodium salt, BioVision), as previously described. 39 Samples were washed twice with PBS and then incubated with the WST-1 reagent
(1:10 dilution in complete medium with phenol red-free DMEM, 50 minutes at 37°C). The absorbance of the collected supernatants was measured with a multiplate reader (Perkin Elmer Victor X3 UV-Vis spectrophotometer); the blank, corresponding to the non-specific absorbance of the WST-1 dilution in phenol red-free DMEM, was subtracted from all measurements. Finally, all data were normalized with respect to the non-treated controls.
Immunofluorescence staining
Immunofluorescence was carried out to detect the expression of the tight junction marker AbBTNPs+US experimental groups and reported in the graph.
Statistics
For multiple sample comparisons, ANOVA followed by Tukey's HSD post-hoc test was performed by using R software (https://www.r-project.org/); regarding the analysis of nanoparticle internalization in bEnd.3 and U-87 cells, independent two-sample t-tests were carried out by using Excel software. Statistically significant differences among distributions were indicated for p < 0.05. Finally, data were plotted in histograms as average ± standard error by using Excel software.
RESULTS
The scheme of the experimental design is represented in Figure 1 . In Figure 1a 
Characterization and imaging of piezoelectric BTNPs
Imaging of piezoelectric BTNPs is presented in Figure S2 . Figure S2a Fourier transformed infrared spectroscopy (FT-IR) was performed in order to verify the successful functionalization of the BTNPs. Starting from the low wavelengths, the peaks in the range 530-600 cm -1 ( Figure S3 ) can be attributed to the Ti-O stretching bond and they are characteristic of the BaTiO 3 compound. 40 Shifting to higher wavelengths, the peak at 1450 cm -1 that can be seen in spectrum i) of plain BTNPs can be attributed to an impurity of BaCO 3 as it has been reported elsewhere. 40 The peaks between 1000-1100 cm -1 (spectrum ii)) are attributed to the C-O-C and C-O-H stretching 41 vibration of the aliphatic chain of poly(ethylene glycol) (PEG), while the peaks in the range 1600-1670 and 1300-1460 cm -1 (spectrum iii)) can be attributed to the Amide I (C=O stretching) 42 and Amide III 40 vibrations of the attached anti-transferrin antibody. The peaks at 2280-2400 and 2850-3000 cm -1 (spectra ii) and iii)) are attributed to the C-H stretching bond of the DSPE-PEG while the peak at 3320 cm -1 (spectrum iii)) can be attributed both to the O-H stretching vibration of the DSPE-PEG/TfR antibody as well as to the Amide A (N-H stretching) 43 of the TfR antibody. The corresponding vibrations and wavelengths are summarized in Table S1 . A small yet significant difference in Z-potential was observed between BTNPs (-29.6 ± 0.8 mV) and AbBTNPs ( BTNPs and Rd = 252 ± 11 nm for AbBTNPs; for t = 110 min, Rd = 304 ± 13 nm for BTNPs and Rd = 280 ± 2 nm for AbBTNPs).
AbBTNPs efficiently target endothelial-like cells and cross BBB model
In order to obtain a functional biological barrier mimicking the BBB, confluent cultures of bEnd.3 cells were maintained in proliferative conditions on 3 µm porous transwell for 1, 3 and 6 days (BBB model characterization is reported in Figure S5 ). Transendothelial electric resistance (TEER) was measured to assess the performances of the barrier at the different time points 
Dual targeting of AbBTNPs
Additionally to the measurements of nanoparticle concentration in the abluminal compartment, the ability of AbBTNPs to efficiently bind glioblastoma cells was tested (Figure 3 
Chronic piezoelectric stimulation inhibits proliferation of human glioblastoma cells
Inhibitory effects of chronic piezoelectric stimulation on U-87 proliferation are shown in Information (Video S1 and S2, respectively). The stability of Ca 2+ levels and the regular proliferation rate observed in response to the plain US stimulation (i.e., without the presence of AbBTNPs) support the safeness of the proposed stimulation method.
Synergic efficacy of remote piezoelectric stimulation with temozolomide treatment
The ability of nanoparticle-assisted piezoelectric stimulation to improve the anticancer efficacy of temozolomide (TMZ) treatment was investigated ( Figure 5 ). Toxic effects of TMZ were assessed by testing different concentrations of the chemotherapy treatment (0-400 μg/ml) at two different time points (24 and 72 h) through WST-1 assay (data are normalized and expressed as percentage of WST-1 absorbance values measured at 24 h on control cultures). Metabolism of U-87 cultures at 72 h of treatment was significantly affected when treating with concentrations at least of 200 μg/ml (Figure 5a ): the best anti-proliferative effects were observed with the highest tested TMZ concentration (400 μg/ml), while first significant effects were observed by using 200 μg/ml. The hypothesis that piezoelectric stimulation could increase the sensitivity of TMZ was investigated by using 50 μg/ml of this chemotherapy drug, the highest concentration that was not effective in our testing conditions (Figure 5b The expression of the Ki-67 proliferation marker and of the p53 tumor suppressor marker in response to 50 μg/ml TMZ, 10 μg/ml AbBTNPs+US, and of 10 μg/ml AbBTNPs+US with 50 μg/ml TMZ (TMZ+AbBTNPs+US) were compared with control cultures and are showed in Figure 5c . Qualitatively, a decreased number of cells and a lower Ki-67 expression were found in both AbBTNP+US and TMZ+AbBTNP+US experimental classes, compared to both control and TMZ. This observation is in line with the lowest metabolism levels reported in response to these treatments. Moreover, a higher amount of p53 + nuclei was detected in response to
TMZ+AbBTNP+US treatment with respect to the other experimental groups. Quantitatively, Ki-67 + nuclei in control (72.4 ± 2.8%) and in TMZ-treated (65.8 ± 5.7%) cultures were significantly higher with respect to the cultures treated with AbBTNP+US (49.2 ± 3.7%; p < 0.05) and with TMZ+AbBTNP+US (27.7 ± 2.5%; p < 0.05), the last of which resulted the strongest antiproliferative treatment (p < 0.05; Figure 5d ). Higher levels of p53 + nuclei were found in response to the combined TMZ+AbBTNP+US therapy (28.3 ± 6.6%; p < 0.05; Figure 5e ) with respect to all the other treatments (1.2 ± 1.3% for AbBTNP+US; 3.4 ± 1.1% for TMZ) and control cultures (1.0 ± 0.7%).
Overall, these results indicate that piezoelectric stimulation affects proliferation of U-87 cells and increases their sensitivity to TMZ. Indeed, TMZ therapy at non-toxic concentrations, when combined with chronic piezoelectric treatment, was able to promote cell apoptosis and reducing cell proliferation.
DISCUSSION
Recent advances in nanobiotechnology are directed to the development of smart and biocompatible sensors / actuators that are able to detect and respond to specific physicochemical conditions in the human body. [45] [46] [47] Piezoelectric nanomaterials are a promising class of nanostructures, that have been successfully exploited both as mechanical sensors for energyharvesting and mechanobiology studies, and as nanostimulators for indirect electrical activation of excitable cells. 48, 49 In this work, we report for the first time the successful crossing of a piezoelectric nanomaterial through a BBB model. Piezoelectric barium titanate nanoparticles used in this study are characterized by a 300 nm diameter size, and resulted able to cross a BBB model with a quite Tf. 57 Therefore, following an approach adopted also by other groups, 58, 59 we performed Summarizing, the main novelties of this research consist in the preparation of piezoelectric nanoceramics able to cross a BBB model, to target glioblastoma cells, and to provide remote electric stimulations for increasing GBM sensitivity to TMZ-based chemotherapy; on the other hand, it is also necessary to underline the limits characterizing the present work, where in vitro models of BBB and GBM were adopted, thus highlighting once more the needing for future in vivo experiments.
CONCLUSIONS
We presented for the first time the preparation of functionalized piezoelectric BTNPs for BBBcrossing, active cancer cell targeting, imaging, and remote US-driven electric treatment.
Moreover, we demonstrated the versatility of this nanotechnological approach, that allows the successful delivery of antiproliferative stimuli to glioblastoma cells. Furthermore, the chronic piezoelectric stimulation, in synergic combination with a sub-toxic concentration of TMZ, induced an increased sensitivity to chemotherapy treatment and remarkable anticancer effects. WST-1 assay respectively performed on control cultures, cultures incubated with 10 μg/ml AbBTNPs, cultures incubated with 50 μg/ml TMZ, cultures incubated with 50 μg/ml TMZ and 10 μg/ml AbBTNPs, cultures chronically stimulated with US, cultures stimulated with US in the presence of 10 μg/ml AbBTNPs, cultures stimulated with US in the presence of 50 μg/ml TMZ, and, finally, cultures stimulated with US in the presence of 10 μg/ml AbBTNPs and of 50 μg/ml TMZ. c) CLSM imaging of Ki-67 and p53 expression in the different experimental conditions. The histograms reporting the Ki-67 + and p53 + nuclei are respectively showed in d) and e). * p < 0.05.
